Current guidelines recommend active surveillance (AS) as the preferred management option for low-risk prostate cancer, and that it may be offered to selected patients with favorable intermediate-risk disease. In some parts of the world, AS has been widely embraced. For example, 91% of men with very low-risk and 74% with low-risk prostate cancer in Sweden are managed by AS. In other countries such as the USA, the majority of men with low-risk prostate cancer still receive upfront treatment.
European urology. 2017 Nov 21 [Epub]
Stacy Loeb
Department of Urology and Population Health, New York University, New York, NY, USA; Manhattan Veterans Affairs Medical Center, New York, NY, USA.
Electronic address: stacyloeb@gmail.com.